A randomized phase II study comparing gemcitabine plus nadroparine versus gemcitabine in patients with locally advanced or metastatic pancreatic carcinoma: The GEMFRAX trial

2016 
4112 Background: Gemcitabine is considered to be the standard chemotherapy regimen for advanced pancreatic cancer. The advantage of gemcitabine over best supportive care however is limited. Preclin...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    3
    Citations
    NaN
    KQI
    []